Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
Appoints Simon Harnest as Chief Financial Officer to advance capital markets and corporate development strategy supporting TOS-358, the Company’s lead covalent PI3Kα inhibitor, and additional ...
Positive Outlook for Relay Therapeutics: Buy Rating on Promising RLY-2680 Developments and Market Opportunities
JMP Securities analyst Silvan Tuerkcan maintained a Buy rating on Relay Therapeutics (RLAY – Research Report) today and set a price target of ...
Jones Trading sets OnKure stock Buy rating, $32 target
Jones Trading initiated coverage on OnKure Therapeutics Inc. (NASDAQ:OKUR) with a Buy rating and a price target of $32.00.